Get the Stockscreener App
2.58
1.15%
-0.03
Anebulo Pharmaceuticals Inc stock is traded at $2.58, with a volume of 4,307.
It is down -1.15% in the last 24 hours and down -17.83% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
See More
Previous Close:
$2.61
Open:
$2.65
24h Volume:
4,307
Relative Volume:
0.04
Market Cap:
$103.18M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-8.60
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
+4.88%
1M Performance:
-17.83%
6M Performance:
+122.41%
1Y Performance:
+41.28%
1-Day Range:
$2.5113
$2.71
1-Week Range:
$2.35
$2.8999
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.5113 | 114.22M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.33 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.94 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.57 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
703.91 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.18 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Real time breakdown of Anebulo Pharmaceuticals Inc. stock performanceMarket Trend Summary & Entry Point Confirmation Alerts - Newser
What MACD and RSI say about Anebulo Pharmaceuticals Inc.Quarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Can momentum traders help lift Anebulo Pharmaceuticals Inc.Forecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
Detecting price anomalies in Anebulo Pharmaceuticals Inc. with AIWeekly Trend Report & AI Powered Market Entry Strategies - Newser
Order flow analysis tools used on Anebulo Pharmaceuticals Inc.Market Performance Recap & Smart Money Movement Alerts - Newser
How high can Anebulo Pharmaceuticals Inc. stock go2025 EndofYear Setup & Precise Swing Trade Alerts - Newser
Should you hold or exit Anebulo Pharmaceuticals Inc. nowJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - Newser
Is Anebulo Pharmaceuticals Inc. stock poised for growthMarket Risk Summary & Risk Managed Investment Strategies - Newser
Analyzing Anebulo Pharmaceuticals Inc. with multi timeframe chartsRate Cut & Low Risk Growth Stock Ideas - Newser
Using AI based signals to follow Anebulo Pharmaceuticals Inc.Earnings Risk Report & Safe Entry Zone Identification - Newser
Volume spikes in Anebulo Pharmaceuticals Inc. stock – what they meanMarket Trend Report & Long-Term Capital Growth Ideas - Newser
How to build a dashboard for Anebulo Pharmaceuticals Inc. stockBuy Signal & Safe Capital Investment Plans - Newser
Using portfolio simulators with Anebulo Pharmaceuticals Inc. includedRecession Risk & Weekly High Potential Stock Alerts - Newser
Can machine learning forecast Anebulo Pharmaceuticals Inc. recovery2025 Price Action Summary & Smart Investment Allocation Tips - Newser
What’s the outlook for Anebulo Pharmaceuticals Inc.’s sectorJuly 2025 Breakouts & High Accuracy Investment Signals - sundaytimes.kr
Using economic indicators to assess Anebulo Pharmaceuticals Inc. potentialQuarterly Earnings Summary & Verified Stock Trade Ideas - Newser
Using fundamentals and technicals on Anebulo Pharmaceuticals Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - Newser
Can Anebulo Pharmaceuticals Inc. outperform under higher oil prices2025 Geopolitical Influence & Verified Technical Trade Signals - sundaytimes.kr
Is Anebulo Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Long term hold vs stop loss in Anebulo Pharmaceuticals Inc.Long Setup & Daily Volume Surge Trade Alerts - Newser
Anebulo Pharmaceuticals Inc. Rebound Backed by Sentiment Shift2025 Volume Leaders & Free High Accuracy Swing Entry Alerts - beatles.ru
What drives Anebulo Pharmaceuticals Inc.’s stock priceJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - theviewers.co.kr
Order Flow Trends Show Accumulation in Anebulo Pharmaceuticals Inc.July 2025 Update & Reliable Entry Point Alerts - kangso.co.kr
Published on: 2025-08-22 05:12:25 - classian.co.kr
Is Anebulo Pharmaceuticals Inc. the Top Chart Pick This WeekJuly 2025 Market Mood & Real-Time Stock Price Movement Reports - beatles.ru
Chart Analysts Warn of Resistance Near Anebulo Pharmaceuticals Inc. Price2025 Volume Leaders & Risk Adjusted Swing Trade Ideas - newsyoung.net
Published on: 2025-08-20 13:13:27 - beatles.ru
How to track smart money flows in Anebulo Pharmaceuticals Inc.Global Markets & Stepwise Trade Execution Plans - Newser
Forecasting Anebulo Pharmaceuticals Inc. price range with options dataMarket Movement Recap & Daily Oversold Stock Bounce Ideas - Newser
Should you wait for a breakout in Anebulo Pharmaceuticals Inc.Portfolio Risk Summary & Real-Time Volume Trigger Notifications - Newser
How to use a screener to detect Anebulo Pharmaceuticals Inc. breakoutsMarket Movement Recap & Fast Entry Momentum Alerts - Newser
Chart based exit strategy for Anebulo Pharmaceuticals Inc.Bond Market & Safe Entry Point Alerts - Newser
Using Ichimoku Cloud for Anebulo Pharmaceuticals Inc. technicalsJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
How to integrate Anebulo Pharmaceuticals Inc. into portfolio analysis toolsMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.78%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):